These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6971642)
1. Calmodulin inhibitors modify cell surface changes triggered by a tumor promoter. Froscio M; Guy GR; Murray AW Biochem Biophys Res Commun; 1981 Feb; 98(3):829-35. PubMed ID: 6971642 [No Abstract] [Full Text] [Related]
2. Possible role of calmodulin in stimulation of hexose transport by 12-O-tetradecanoylphorbol-13-acetate, a tumor promoter. Yamanishi K; Nishino H; Iwashima A Experientia; 1983 Sep; 39(9):1036-7. PubMed ID: 6884492 [TBL] [Abstract][Full Text] [Related]
3. Antagonism of concanavalin A capping in phorbol ester-activated lymphocytes by calmodulin inhibitors and certain amino acid esters. Kwong CH; Mueller GC Cancer Res; 1982 Jun; 42(6):2115-20. PubMed ID: 7200397 [TBL] [Abstract][Full Text] [Related]
4. Interaction of tumor promoters and growth factors with cultured cells. Bowden GT; Matrisian LM; Lockyer JM; Magun BE Carcinog Compr Surv; 1982; 7():463-9. PubMed ID: 6279295 [No Abstract] [Full Text] [Related]
5. Inhibition of histidine decarboxylase and tumour promoter-induced arachidonic acid release by lecanoric acid analogues. Umezawa K; Muramatsu S; Ishizuka M; Sawa T; Takeuchi T; Matsushima T Biochem Biophys Res Commun; 1983 Feb; 110(3):733-9. PubMed ID: 6404261 [TBL] [Abstract][Full Text] [Related]
6. Activation of calcium and phospholipid-dependent protein kinase by epidermal growth factor (EGF) in A431 cells: attenuation by 12-0-tetradecanoylphorbol-13-acetate (TPA). Sahai A; Smith KB; Panneerselvam M; Salomon DS Biochem Biophys Res Commun; 1982 Dec; 109(4):1206-14. PubMed ID: 6220697 [No Abstract] [Full Text] [Related]
7. Inhibition of epidermal growth factor binding to surface receptors by tumor promotors. Brown KD; Dicker P; Rozengurt E Biochem Biophys Res Commun; 1979 Feb; 86(4):1037-43. PubMed ID: 312103 [No Abstract] [Full Text] [Related]
8. Ca-calmodulin mediates the DNA-synthetic response of calcium-deprived liver cells to the tumor promoter TPA. Jones A; Boynton AL; MacManus JP; Whitfield JF Exp Cell Res; 1982 Mar; 138(1):87-93. PubMed ID: 7067742 [No Abstract] [Full Text] [Related]
9. Inhibition of epidermal growth factor binding by phorbol esters, saccharin, and cyclamate and its implications in the mechanism of tumor promotion. Lee LS Carcinog Compr Surv; 1982; 7():471-5. PubMed ID: 6279296 [No Abstract] [Full Text] [Related]
10. Similar effects of phospholipase C and phorbol ester tumor promoters on primary mouse epidermal cells. Jeng AY; Lichti U; Strickland JE; Blumberg PM Cancer Res; 1985 Nov; 45(11 Pt 2):5714-21. PubMed ID: 3931907 [TBL] [Abstract][Full Text] [Related]
11. Modulation of peptide binding to specific receptors on rat pituitary cells by tumor-promoting phorbol esters: decreased binding of thyrotropin-releasing hormone and somatostatin as well as epidermal growth factor. Osborne R; Tashjian AH Cancer Res; 1982 Nov; 42(11):4375-81. PubMed ID: 6127158 [No Abstract] [Full Text] [Related]
12. Stimulation of choline incorporation in cell cultures by phorbol derivatives and its correlation with their irritant and tumor-promoting activity. Kinzel V; Kreibich G; Hecker E; Süss R Cancer Res; 1979 Jul; 39(7 Pt 1):2743-50. PubMed ID: 571760 [No Abstract] [Full Text] [Related]
13. Changes in epidermal growth factor receptors associated with adenovirus transformation, chemical carcinogen transformation and exposure to a phorbol ester tumor promoter. Fisher PB; Lee LS; Weinstein IB Biochem Biophys Res Commun; 1980 Apr; 93(4):1160-6. PubMed ID: 6249279 [No Abstract] [Full Text] [Related]
14. Effects of 12-0-Tetradecanoylphorbol-13-acetate (TPA) on rat pheochromocytoma (PC12) cells: interactions with epidermal growth factor and nerve growth factor. End D; Tolson N; Yu MY; Guroff G J Cell Physiol; 1982 May; 111(2):140-8. PubMed ID: 6979547 [TBL] [Abstract][Full Text] [Related]
16. Role of differentiation in determining responses of epidermal cells to phorbol esters. Hennings H; Lichti U; Holbrook K; Yuspa SH Carcinog Compr Surv; 1982; 7():319-23. PubMed ID: 7066923 [No Abstract] [Full Text] [Related]
17. Tumor promoter stimulation of phosphatidylcholine turnover in HeLa cells. Guy GR; Murray AW Cancer Res; 1982 May; 42(5):1980-5. PubMed ID: 7066909 [TBL] [Abstract][Full Text] [Related]
18. Effects of a tumor promoter on phospholipid metabolism in HeLa cells. Guy GR; Murray AW Cancer Res; 1983 Nov; 43(11):5564-9. PubMed ID: 6616483 [TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor. Ability of tumor promoter to alter its degradation, receptor affinity and receptor number. Magun BE; Matrisian LM; Bowden GT J Biol Chem; 1980 Jul; 255(13):6373-81. PubMed ID: 6967066 [No Abstract] [Full Text] [Related]
20. Mechanism of tumor promoter inhibition of cellular binding of epidermal growth factor. Lee LS; Weinstein IB Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5168-72. PubMed ID: 315558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]